Influenza Vaccination Guidelines

Standard Vaccination Schedule

The Advisory Committee on Immunization Practices (ACIP) recommends annual influenza vaccination, which means one dose per influenza season for most individuals 1, 2, 3
Adults and children ≥9 years require only one dose per season 1, 2
Children 6 months through 8 years may require two doses in their first season of vaccination, but this is for initial priming, not repeated vaccination within subsequent seasons 1, 2
The Centers for Disease Control and Prevention (CDC) states that repeated immunization within the same season is not recommended, even though antibody responses to repeat immunization have been reported to be greater in some people with diabetes 4

Each year's influenza vaccine is specifically formulated to protect against the 3-4 strains expected to circulate during that upcoming season 5, 2
Giving additional doses of the same formulation within the same season does not enhance protection against those specific strains 1, 4
Antibody levels decline over the year, which is why annual revaccination is necessary for the next season 4

Patients with COPD should receive one dose of inactivated influenza vaccine annually, not multiple doses 1, 6
The American College of Cardiology recommends that patients with cardiovascular disease receive one dose of inactivated influenza vaccine annually as secondary prevention 5, 7
The American Heart Association/American College of Cardiology recommends annual influenza vaccination as Class I, Level B recommendation for individuals with coronary and other atherosclerotic vascular disease 5, 7
Live attenuated vaccine (FluMist) should not be used in patients with cardiovascular disease or COPD because it can cause influenza illness in these high-risk populations 5, 1, 6

Vaccination should occur between September and November for optimal protection, though vaccination should continue throughout the influenza season as long as vaccine is available 5, 1, 3
Timing maximizes benefit before typical influenza activity onset (January-March peak in the United States) 5, 1
Late season vaccination is still beneficial if vaccine supply was delayed or patient missed earlier opportunities 5, 1

Do not give multiple doses of the same seasonal vaccine formulation—this provides no additional benefit and wastes vaccine resources 1, 4
Do not use live attenuated vaccine (FluMist) in COPD or heart disease patients—only inactivated vaccines are appropriate for these high-risk groups 5, 1, 6
Do not delay vaccination waiting for a "better" time within the season—earlier vaccination (September-November) is optimal 5, 1, 3

The American Academy of Pediatrics and Centers for Disease Control and Prevention explicitly state that vaccination should not be delayed to obtain a specific product, and any available age-appropriate trivalent or quadrivalent vaccine can be used, with different brands usable for different doses in the same season 8
For children requiring 2 doses (ages 6 months through 8 years), the two doses need not be the same brand or formulation, although a child who receives only 1 of the 2 doses as a quadrivalent formulation is likely to be less primed against the additional influenza B virus 8
The Advisory Committee on Immunization Practices makes no preferential recommendation for any influenza vaccine product over another when more than one licensed product appropriate for age and health status is available, with the exception of adults ≥65 years who should preferentially receive higher-dose or adjuvanted vaccines 9, 10, 11

Different brands contain the same antigenic composition each season (same influenza strains), making them interchangeable for the same age group 12
Trivalent and quadrivalent formulations can be mixed, with neither vaccine formulation preferred over the other, and pediatricians should administer whichever formulation is available in their communities 8
The key consideration is age-appropriateness, not brand consistency, with each vaccine having specific FDA-approved age indications that must be followed, but within those indications, any brand is acceptable 9, 13

For children 6 months through 8 years requiring 2 doses, the interval between doses should be at least 4 weeks, but the brands do not need to match 8, 10
Previous doses from any season count toward priming, with the 2 previous doses not needing to have been received during the same influenza season or consecutive influenza seasons, and they do not need to be the same brand 8

The Centers for Disease Control and Prevention and the American Academy of Pediatrics recommend not delaying vaccination waiting for a specific brand, as timely vaccination is more important than brand consistency 8, 9, 11
Previous doses with different brands still count toward completion of the recommended series, and brand switching does not require restarting the series 8
It is essential to verify age-appropriateness, as not all vaccines are licensed for all ages, and the specific age indication for each product should be checked 9, 13